Overview
- Revenue fell about 4% to roughly €5.5 billion, and EBITDA declined 42% to €430 million, with management saying the group would have posted a loss even without one-off charges.
- Impairments totaled about €600 million, including roughly €310 million on the 31% Siltronic stake, and a restructuring provision of about €100 million weighed on results.
- Wacker is implementing its ‘Pace’ program targeting more than €300 million in annual savings by end-2027, including about 1,500 job cuts, with initial measures already underway.
- The MDax-listed shares fell around 4% intraday after early gains, while Warburg Research maintained a buy rating with an €88 price target.
- Management plans to sharpen the portfolio toward chemical specialties, semiconductor-grade polysilicon and biosolutions, and continues to urge policy action on industrial power prices as the company uses nearly 1% of Germany’s electricity.